CD274 and cancer: The interaction between PD-1 in the cytotoxic T lymphocyte and PD-L1 in the cancer cell decreases the activity of T cells by several mechanisms, including the inhibition of the T cell receptor downstream signaling [5,6], the enhancement of regulatory T cells [7], and the decrease in B cells and natural killer activities [8].